CRSP edges ahead of NTLA with the only approved CRISPR therapy, stronger pipeline breadth and recent stock gains.

CRISPR-Cas9 genome editing exploits the CRISPR-Cas system to modify a genome in a targeted manner. Guided by RNA, the Cas9 endonuclease breaks DNA at a target sequence. Imprecise repair of the ...

A recent study involving researchers from the University of Basel reveals that slowing down the intracellular transport of ...

CRSP bets on Casgevy to drive growth, but its extremely high price tag and slow rollout test investor patience in a crowded ...

A recent study involving researchers from the University of Basel reveals that slowing down the intracellular transport of ...

Researchers at the IPK Leibniz Institute have discovered a previously unknown protein that is central to plant reproduction.

Sickle Cell Disease Market Insight, Epidemiology And Market Forecast - 2034The sickle cell disease treatment market is experiencing signific ...

Cells depend on the precise reading of DNA sequences to function correctly. This process, known as gene expression, ...